We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
+21.35%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$2.04B
AUM Growth
+$120M
Cap. Flow
-$149M
Cap. Flow %
-7.33%
Top 10 Hldgs %
47.27%
Holding
257
New
21
Increased
32
Reduced
47
Closed
104

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$16.4M
2
TRAX
First Tracks Biotherapeutics
TRAX
+$14M
3
SE icon
Sea Limited
SE
+$11.9M
4
NU icon
Nu Holdings
NU
+$10.1M
5
GOSS icon
Gossamer Bio
GOSS
+$9.54M

Top Sells

Rank Stock Value
1
ASTH icon
Astrana Health
ASTH
+$17.6M
2
LLY icon
Eli Lilly
LLY
+$15.3M
3
GXO icon
GXO Logistics
GXO
+$14.8M
4
FOLD
Amicus Therapeutics
FOLD
+$11.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.9%
2 Healthcare 24.5%
3 Financials 7.3%
4 Consumer Discretionary 7.28%
5 Technology 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
U icon
26
Unity
U
$18.9B
$17.6M 0.86%
+615,000
New +$16.4M
WAL icon
27
Western Alliance Bancorporation
WAL
$8.6B
$16.4M 0.81%
200,000
-25,000
-11% -$1.97M
IAG icon
28
IAMGOLD
IAG
$11.8B
$16M 0.79%
1,010,000
-40,000
-4% -$699K
ELV icon
29
Elevance Health
ELV
$86.9B
$15.5M 0.76%
40,000
– –
TRAX
30
First Tracks Biotherapeutics
TRAX
$1.45B
$15.1M 0.74%
+750,000
New +$14M
KNOP icon
31
KNOT Offshore Partners
KNOP
$391M
$15M 0.74%
1,505,000
+25,000
+2% +$266K
QURE icon
32
CALL
uniQure
QURE
$3.22B
$14.6M 0.72%
316,200
-937,400
-75% -$24.5M
SRPT icon
33
Sarepta Therapeutics
SRPT
$2.34B
$14.1M 0.69%
782,500
+32,500
+4% +$615K
UNH icon
34
UnitedHealth
UNH
$353B
$13.3M 0.65%
32,000
– –
SE icon
35
Sea Limited
SE
$67.2B
$12.9M 0.64%
+135,000
New +$11.9M
GOOGL icon
36
Alphabet (Google) Class A
GOOGL
$4.05T
$12.5M 0.61%
35,000
-1,000
-3% -$360K
ZVRA icon
37
Zevra Therapeutics
ZVRA
$724M
$12.3M 0.6%
855,000
-120,000
-12% -$1.33M
GPC icon
38
Genuine Parts
GPC
$18.6B
$11.9M 0.59%
101,000
-4,000
-4% -$417K
ARIS
39
Aris Mining
ARIS
$4.17B
$11.5M 0.56%
770,000
-30,000
-4% -$539K
IFRX icon
40
InflaRx
IFRX
$314M
$11.3M 0.56%
5,065,000
+1,750,000
+53% +$3.29M
CPNG icon
41
Coupang
CPNG
$26.7B
$11.3M 0.55%
650,000
+40,000
+7% +$722K
MRNA icon
42
PUT
Moderna
MRNA
$54.9B
$10.9M 0.54%
156,000
– –
GXO icon
43
GXO Logistics
GXO
$5.27B
$10.9M 0.54%
215,000
-285,000
-57% -$14.8M
HRMY icon
44
Harmony Biosciences
HRMY
$2.43B
$10.7M 0.53%
+294,000
New +$9.27M
ALNY icon
45
Alnylam Pharmaceuticals
ALNY
$34.2B
$10.5M 0.52%
35,000
+14,000
+67% +$4.22M
NU icon
46
Nu Holdings
NU
$73.5B
$10M 0.49%
+750,000
New +$10.1M
HHH icon
47
Howard Hughes
HHH
$3.73B
$10M 0.49%
140,000
+104,500
+294% +$6.8M
ASTH icon
48
Astrana Health
ASTH
$1.89B
$9.75M 0.48%
210,000
-490,000
-70% -$17.6M
ENVA icon
49
Enova International
ENVA
$5.59B
$9.63M 0.47%
40,000
– –
SDRL icon
50
Seadrill
SDRL
$3.04B
$9.08M 0.45%
240,000
-10,000
-4% -$466K
1
2
3 4 5

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, 683 Capital Management held 257 positions worth $2.04B, up 6.3% from $1.92B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

683 Capital Management withdrew a net $149M in Q2 2026, closing 104 positions and reducing 47 holdings. Its most notable exit was Eli Lilly, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 683 Capital Management opened a new position in Unity worth $17.6M.

  • 683 Capital Management's largest Q2 2026 buy was Unity: 615,000 shares worth $17.6M.
  • 683 Capital Management added most to Gossamer Bio in Q2 2026, an estimated $9.54M increase.
  • 683 Capital Management's biggest Q2 2026 reduction was Astrana Health, cutting an estimated $17.6M.
  • 683 Capital Management fully exited Eli Lilly in Q2 2026, selling an estimated $15.3M.
  • 683 Capital Management's ten largest holdings make up 47% of its $2.04B portfolio in Q2 2026.
  • 683 Capital Management opened 21 new positions and closed 104 in Q2 2026.
  • 683 Capital Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.